Skip to main content
. 2006 Jan;82(963):46–51. doi: 10.1136/pgmj.2005.032862

Table 3 Treatment and outcomes of patients with spinal tuberculosis.

Number Treatment Surgery Corticosteroids Duration of treatment Residual symptoms and signs
1 RIPE None 12 None
2 RIPE T2/T3 vertebrectomy, bone graft, posterior instrumented fusion (C4–T7) Y 15 Back pain
3 RIPE None Y 12
4 RIPE T6 vertebrectomy, posterior spinal fusion with pedicular screws and rod instrumentation from T3 to T9 14 UMN signs lower limbs
5 RIPE None Y 13 Kyphosis T8–10
6 RIPE None 14 Back stiffness
7 RIPE None 9 Back pain
8 RIPE None 12 None
9 RIPE None 9 L'hermittes phenomenon
10 RIPE None 12 None
11 RIPE I and D of paravertebral mass Y T/O
12 RIPE None T/O
13 RIPE None Y T/O
14 RIPE T11 and 12 debridement and bone graft 9 None
15 RIPE None 12 None
16 RIPE None Y 12 Gibus (T10), scoliosis, limited flexion, reduced sensation S1 dermatome
17 RPE None 20 Gibbus and mild kyphosis
18 RIPE Transoral decompression of cervical abscess. Removal of odontoid process and lateral edge of the atlas. 13 Neck shortening, limited lateral rotation bilateral (10°) and flexion/extension
19 RIPE None 24 Back pain
20 RIPE then ETH, cycloserine, PAS, clarithro Rod instrumentation C1–C4 34 (T/O) Dysphagia
21 RIPE None 18 Pleuritic chest pain

RIPE, rifampicin, isoniazid, pyrazinamide, ethambutol; I and D, incision and drainage; T, thoracic; Y, yes; T/O, treatment ongoing; UMN, upper motor neurone lesion.